18.99  0 (0%)		10-20 16:00
Open: 18.99 High: 18.99 Volume: 653,573		Pre. Close: 18.99 Low: 18.99 Market Cap: 536(M)

Short term
Mid term
Targets	6-month :		1-year :
Resists	First :		Second :
Pivot price
Supports	First :		Second :
MAs	MA(5) :		MA(20) :
	MA(100) :		MA(250) :
MACD	MACD :		Signal :
%K %D	K(14,3) :		D(3) :
RSI	RSI(14):
52-week	High :		Low :

If tomorrow:	Open lower	Open higher
High:	-	-
Low:	-	-
Close:	-	-

ZimVie Inc. operates as a medical technology enterprise, specializing in the design, manufacturing, and global distribution of an extensive array of products and solutions. These offerings are engineered to address various spinal conditions and facilitate dental tooth replacement and restorative procedures. Its comprehensive dental portfolio encompasses implant systems, along with associated prosthetic and abutment components, and the necessary surgical instrumentation and kits. The company also supplies advanced regenerative products such as bone grafts, barrier membranes, allografts, and collagen-based wound care solutions. Furthermore, it provides cutting-edge digital dentistry tools, including intraoral scanners, virtual treatment planning services, guided surgery capabilities, CAD/CAM workflow systems, and customized restorative parts. In the spinal segment, ZimVie offers a range of fusion implants and specialized instrumentation for diverse surgical interventions, including biologics and innovative bone healing technologies. Notably, its specialized spinal offerings include minimally invasive surgery (MIS) solutions, exemplified by products like Vital MIS and Timberline, as well as advanced motion preservation technologies such as Mobi-C and The Tether. Established in 2021, ZimVie Inc. maintains its corporate headquarters in Westminster, Colorado.

Mon, 20 Oct 2025
ARCHIMED Completes Acquisition of ZimVie Inc. in Strategic Move to Enhance Dental Implant Solutions - Quiver Quantitative

Mon, 20 Oct 2025
$19.00 Per Share: ZimVie Becomes Private After ARCHIMED Acquisition; NASDAQ Delisted - Stock Titan

Thu, 31 Jul 2025
ZimVie Inc. Reports Q2 2025 Results Amid Acquisition - The Globe and Mail

Fri, 25 Jul 2025
ZimVie to Announce Q2 Results July 30 - Dentistry Today

Wed, 23 Jul 2025
ZimVie Inc. Enters Strategic Distribution Agreement with Osstem Implant to Expand Presence in China’s Dental Implant Market - Quiver Quantitative

Mon, 21 Jul 2025
EX-99.1 - SEC.gov

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	(%)
Held by Institutions	(%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS
EPS Est Next Qtrly
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin	%
Operating Margin	%
Return on Assets (ttm)	%
Return on Equity (ttm)	%
Qtrly Rev. Growth	%
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth	%
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Dividend
Forward Dividend
Dividend Yield	0%
Dividend Pay Date
Ex-Dividend Date